Benefits and Risks of Direct-to-Consumer Testing

被引:16
|
作者
Ayala-Lopez, Nadia [1 ]
Nichols, James H. [2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA
关键词
D O I
10.5858/arpa.2020-0078-RA
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Convenience, avoidance of doctor's appointments, curiosity, and the desire to take control of one's health are driving interest toward direct-to-consumer (DTC) testing. DTC is laboratory testing that is initiated by the consumer without a physician order. The results are reported back directly to the consumer. DTC testing is an exciting addition to the traditional healthcare model for consumers who want knowledge of their health status and disease risk, ancestry, and their body's expected response to certain medications based on their genotype. Objectives.-To discuss the perceived and potential benefits and risks involved in DTC testing. Data Sources.-Recent published literature on DTC testing. Conclusions.-The benefits of DTC testing are enticing and are driving the DTC testing market. Consumers must weigh the perceived benefits with the potential risks, including privacy concerns, the possibility of receiving confusing health information, and/or information that could generate unexpected emotions, misdiagnosis, and over-testing.
引用
收藏
页码:1193 / 1198
页数:6
相关论文
共 50 条
  • [41] The ethics and regulation of direct-to-consumer genetic testing
    Paula Boddington
    Genome Medicine, 1
  • [42] Public Perspectives on Direct-to-Consumer Testing Oversight
    Jiang, Sharon
    Lebo, David
    Schultz, Thomas
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (06) : 1027 - 1030
  • [43] Direct-to-consumer genetic testing - clinical considerations
    Trent, Ronald J.
    MEDICAL JOURNAL OF AUSTRALIA, 2013, 198 (09) : 496 - 498
  • [44] Regulating Direct-to-Consumer Personal Genome Testing
    McGuire, Amy L.
    Evans, Barbara J.
    Caulfield, Timothy
    Burke, Wylie
    SCIENCE, 2010, 330 (6001) : 181 - 182
  • [45] Direct-to-Consumer Genetic Testing: Reliable or Risky?
    Spencer, David H.
    Lockwood, Christina
    Topol, Eric
    Evans, James P.
    Green, Robert C.
    Mansfield, Elizabeth
    Tezak, Zivana
    CLINICAL CHEMISTRY, 2011, 57 (12) : 1641 - 1644
  • [46] Direct-to-Consumer Genetic Testing: Value and Risk
    Majumder, Mary A.
    Guerrini, Christi J.
    McGuire, Amy L.
    ANNUAL REVIEW OF MEDICINE, VOL 72, 2021, 2021, 72 : 151 - 166
  • [47] Costs and Benefits of Direct-to-Consumer AdvertisingThe Case of Depression
    Adam E. Block
    PharmacoEconomics, 2007, 25 : 511 - 521
  • [48] Direct-to-consumer genetic testing - a regulatory nightmare?
    Nicol, Dianne
    Hagger, Meredith
    MEDICAL JOURNAL OF AUSTRALIA, 2013, 198 (09) : 501 - 502
  • [49] Direct-to-consumer advertising of genetic testing - Reply
    Gollust, SE
    Hull, SC
    Wilfond, B
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (01): : 46 - 46
  • [50] Direct-to-Consumer Genetic Testing for Domestic Cats
    Lyons, Leslie A.
    Buckley, Reuben M.
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2020, 50 (05) : 991 - +